Targeting Ischemic Disease with DiaMedica CEO Rick Pauls
May 6, 202629 min
Show notes
In this week’s episode of the Xtalks Life Science Podcast, host Ayesha Rashid, Senior Life Science Journalist at Xtalks, spoke Rick Pauls, President and CEO of DiaMedica Therapeutics (Nasdaq: DMAC), a company advancing multiple programs in challenging vascular conditions driven by ischemia, including preeclampsia (PE), fetal growth restriction (FGR) and acute ischemic stroke (AIS). DiaMedica’s therapeutic approach in ischemia-based diseases centers on a recombinant form of the KLK1 protein, which plays a key role in regulating blood flow, reducing inflammation and supporting vascular health. Rick Pauls has served as President and CEO of DiaMedica since 2009 and has been a board member since 2005, including as Chair from 2008 to 2014. Previously, he co-founded and led CentreStone Ventures, an early-stage life sciences venture capital fund, worked as an analyst at Centara Corporation and specialized in asset-backed securitization and structured finance at General Motors Acceptance Corporation. He has also served on the boards of several public and private companies. Rick received his BA in Economics from the University of Manitoba and his MBA in Finance from the University of North Dakota. Tune in to hear about a novel therapeutic approach to treating ischemia-driven diseases like stroke and preeclampsia. For more life science and medical device content, visit the Xtalks Vitals homepage. https://xtalks.com/vitals/ Follow Us on Social Media Twitter: https://twitter.com/Xtalks Instagram: https://www.instagram.com/xtalks/ Facebook: https://www.facebook.com/Xtalks.Webinars/ LinkedIn: https://www.linkedin.com/company/xtalks-webconferences YouTube: https://www.youtube.com/c/XtalksWebinars/featured
Transcript
Transcript not available for this episode yet.
More from Xtalks Life Science Podcast
Sustainability in Asthma and COPD Drug Development with Chiesi’s Diego Ardigò
Jun 10, 202624 min
What’s Next in Cardiometabolic Disease Drug Development: Obesity, MASH and Beyond with MetaVia’s Hyung Heon Kim
Jun 4, 202626 min
How Real-World Evidence Is Shaping Inclusive Clinical Trials with Takeda CMO Dr. Awny Farajallah
May 27, 202637 min
Stem Cell Therapies for Degenerative Disc Disease and More with BioRestorative’s Lance Alstodt
May 20, 202638 min
New Blood Test for Early Alzheimer’s Detection with FNIH’s Dr. Alessio Travaglia
May 13, 202630 min